LISA VELASQUEZ: Open Payments
NPI 1821637208 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 41 payments from 13 companies in 2025. Trend: 2023 $876 · 2024 $440 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $173 |
| Novo Nordisk Inc | 12 | $171 |
| Corcept Therapeutics | 3 | $169 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| PFIZER INC. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Exact Sciences Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Korlym, MOUNJARO, Wegovy, JARDIANCE, BREZTRI, LEQVIO, Ozempic, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
